Nashua, NH, January 13, 2026 – Consumer health company AcuDart Health today announced that its Tick-Borne Disease (TBD) test panel—which detects Lyme disease, Tick-Borne Relapsing Fever (TBRF), Bartonellosis, and Babesiosis—is now available for order in Canada. Launched in the United States in August 2024, the test is now accessible to Canadians with no doctor authorization required.
Lyme disease, the most common TBD in Canada, has seen a sharp increase since it became nationally notifiable in 2009. According to preliminary 2024 data from the Public Health Agency of Canada (PHAC), 5,239 cases were reported, the highest annual total on record. Experts note that the official count likely underestimates the true burden, as many infections go undetected.
Rising case numbers are linked to the northward expansion of tick habitats due to climate change, increased human exposure to risk areas, and improved clinical and public awareness. Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted by deer ticks. Symptoms include fever, headache, fatigue, chills, and joint or muscle pain.
AcuDart Offers Superior Accuracy
Low accuracy of tick-borne disease tests has been an issue for decades. Many patients are routinely misdiagnosed and end up suffering for years. AcuDart tests are able to achieve higher accuracy because they look for antibodies to more species of a disease. In the case of Lyme disease, whereas most tests look for an immune response to only one or two species, the AcuDart Lyme disease test detects antibodies to nine Lyme-causing species. This results in an accuracy considerably higher than that of the two-tier testing protocol recommended by the United States CDC, as well as tests from industry leaders CVS and Everlywell.
Diagnosis of any TBD based on clinical grounds is very challenging because symptoms can mimic many other diseases. These diseases can also affect any organ of the body, including the brain and nervous system, muscles and joints, and the heart. Only with accurate and reliable testing can patients determine if they have a TBD.
AcuDart kits ship in a lightweight and environmentally friendly pouch.
Key features of the AcuDart tests
- Screens for 19 markers across Lyme disease, TBRF, Babesiosis, and Bartonellosis
- Completed at home
- Fast and free FedEx shipping both ways in USA and Canada
- No doctor authorization required
- Can be purchased for others
- Five year shelf life so you can stock up
- Detects antibodies to more species than competing tests
